Read here for an analysis of early demand for Quantum's TFLN photonic chips and potential risks from competition and ...

Yesterday, Powell spoke that truth – the market did not like it. Powell said, "The economy is not sending any signals that we ...

Principal Financial upgraded to buy, showing growth potential in insurance premiums and fees. Strong credit ratings and ...

Concerns over Trump's re-election and tariffs impact iShares MSCI China ETF performance, highlighting the importance of ...

Supermicro risks NASDAQ delisting due to filing delays. Find out why SMCI stock could react to a potential report release and ...

New Tea Room Opens in Colorado Springs ...

An analyst tweeted on November 14 that the S&P 500 equity risk premium has significantly shrunk, reaching near zero lows, the ...

Nektar continues to make progress with rezpegaldesleukin, with results from phase 2 atopic dermatitis study expected in H1'25 ...

TIGR's top line rose by +44% YoY in Q3 2024 as its trading volume more than doubled for the recent quarter. Explore more ...

Of course, every opportunity in the market carries risks. For URAA, the 2X leverage makes the ETF wildly choppy. In addition, ...

Altimmune’s lead drug Pemvidutide demonstrates significant progress in obesity and liver health. See why ALT stock is a ...

Q3 2024 Earnings Call Transcript November 11, 2024 Operator: Greetings and welcome to the Fulgent Genetics Q3 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode ...